Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1997-08-05
Haley, Jacqueline
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514314, 514327, 514329, 514331, 5142278, 5142325, 544 62, 544128, A61K 3147, C07D40112
Patent
active
056543166
ABSTRACT:
The invention relates to compounds of the formula ##STR1## wherein X, i, j, n, n', A, A', R.sub.2, R.sub.3, and U are as described herein. The compounds of the invention are NK.sub.1 or NK.sub.2 or NK.sub.3 receptor antagonists and as such are useful in the treatment of diseases such as asthma.
REFERENCES:
patent: 5350852 (1994-09-01), Emonds-Alt et al.
patent: 5387595 (1995-02-01), Mills
patent: 5411971 (1995-05-01), Emonds-Alt
patent: 5434158 (1995-07-01), Shah
Alaimo Cheryl A.
Carruthers Nicholas I.
Blasdale John
Boxer Matthew
Haley Jacqueline
Schering Corporation
LandOfFree
Piperidine derivatives as neurokinin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivatives as neurokinin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives as neurokinin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1075088